The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells (Q64097360)

10

object named as

Barak Rotblat

0 references

Arndt Borkhardt

6

object named as

Arndt Borkhardt

0 references

author name string

Gal Mazor

1

0 references

Liron Levin

2

0 references

Daniel Picard

3

0 references

Ulvi Ahmadov

4

0 references

Helena Carén

5

0 references

Gabriel Leprivier

8

0 references

Marc Remke

Creative Commons Attribution 4.0 International

9

0 references

language of work or name

English

0 references

publication date

13 March 2019

0 references

published in

Cell Death and Disease

0 references

volume

10

0 references

issue

3

0 references

page(s)

246

0 references

copyright license

start time

1 March 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

DESeq2

object named as

DeSeq2

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Advances in the molecular genetics of gliomas - implications for classification and therapy

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Cancer stem cells in glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

A restricted cell population propagates glioblastoma growth after chemotherapy

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Role of AHR and HIF-1α in Glioblastoma Metabolism

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The evolution of lncRNA repertoires and expression patterns in tetrapods

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

RNA maps reveal new RNA classes and a possible function for pervasive transcription

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The landscape of long noncoding RNAs in the human transcriptome

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Long non-coding RNAs: new players in cell differentiation and development

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Enhancers as non-coding RNA transcription units: recent insights and future perspectives

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Long noncoding RNAs and human disease

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Long Noncoding RNAs in Cancer Pathways

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

A long non-coding RNA signature in glioblastoma multiforme predicts survival.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Long noncoding RNA: noncoding and not coded

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Local regulation of gene expression by lncRNA promoters, transcription and splicing.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

An ID2-dependent mechanism for VHL inactivation in cancer

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

p63 and p73, the ancestors of p53.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

p73 regulates maintenance of neural stem cell.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Aldehyde dehydrogenase 1A1 in stem cells and cancer

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The long non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain glioma growth through HMGB1/RAGE pathway.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Interaction of hypoxia-inducible factor-1α and Notch signaling regulates medulloblastoma precursor proliferation and fate.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Metabolic state of glioma stem cells and nontumorigenic cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.

1 reference

https://api.crossref.org/works/10.1038/S41419-019-1477-5

7 January 2021

Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30867410

12 December 2020

inferred from PubMed ID database lookup

Glioma epigenetics: From subclassification to novel treatment options

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30867410

12 December 2020